BridgeBio Pharma, Inc.

NASDAQ:BBIO

25.2 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 547.367475.353375.935505.213302.438407.368376.689483.235470.098371.55393.772180.347378.42471.176356.082366.967540.919757.049363.773413.973293.803373.027436.086-91.995
Short Term Investments 39.81344.46958.94938.052333.30734.12295.233108.742245.607299.676442.891419.264459.243447.942251.011343.714300.02148.126182.22122.08000183.99
Cash and Short Term Investments 587.18519.822434.884505.213333.307441.49428.269591.977715.705671.226787.515599.611898.351919.118607.093710.681840.939928.385577.137536.053293.803373.027436.08691.995
Net Receivables 0.66235.4941.7515.178.61410.76117.07924.58122.82110.98319.7498.17244.3250.46208002.84500000
Inventory 0016.65316.65219.9325.50337.93000001.21300000-2.84500000
Other Current Assets 28.39628.10824.30522.58320.54625.14521.92225.66132.75434.02132.44631.92726.6725.53435.73126.70320.99619.78222.62913.3525.3742.2762.050
Total Current Assets 616.236783.424477.593549.618382.397502.899505.2642.219771.28716.23839.71639.71970.559945.114642.824745.384861.935948.167599.766558.155306.709382.473445.22391.995
Non-Current Assets:
Property, Plant & Equipment, Net 17.10719.46619.84321.74522.86124.09825.24727.34129.72331.11845.97344.84942.23635.81336.83325.82626.03824.615.6252.9841.8651.8821.5750
Goodwill 000000000000000000000000
Intangible Assets 25.12325.72126.31926.91727.51528.11328.71229.3129.90830.47644.93446.204000000000000
Goodwill and Intangible Assets 25.12325.72126.31926.91727.51528.11328.71229.3129.90830.47644.93446.204000000000000
Long Term Investments 119.1483.9433.74438.05250.48749.80343.65311.612.4082.46649.14817.70718.89482.20200023.2131.14476.7937.49512.45217.050
Tax Assets 0-0-3.7440000-11.61-2.408-2.46600000000000000
Other Non-Current Assets 16.76116.77922.62518.67620.40120.76720.22429.8731.32232.85933.02733.05449.79730.17923.93116.48317.254-6.188-4.8562.5989.4714.5671.093-91.995
Total Non-Current Assets 178.13965.90968.787105.39121.264122.781117.83686.52190.95396.919173.082141.814110.927148.19460.76442.30943.29241.63231.91382.37518.83118.90119.718-91.995
Total Assets 794.375849.333546.38655.008503.661625.68623.036728.74862.233813.1491,012.792781.5241,081.4861,093.308703.588787.693905.227989.799631.679640.53325.54401.374464.9410
Liabilities & Equity:
Current Liabilities:
Account Payables 18.1264.72810.6554.4723.8744.07611.55810.1588.79310.10711.88412.03522.32910.348.9459.83912.83513.0868.85210.2716.06512.34413.5090
Short Term Debt 4.6234.5444.1284.1373.7763.6743.6754.0444.314.3634.9384.9994.547.4531.4583.6173.6272.51800000
Tax Payables 000000000000000000000000
Deferred Revenue 15.09813.9576.0966.5926.216.6758.1567.5187.19000-4.54075.957.05370.90243.26931.45500000
Other Current Liabilities 96.517118.248122.96586.72792.48478.49794.36497.474120.86788.993113.30978.789105.0476.9365.555.1985.2763.5394.07829.58822.6423.12819.0680
Total Current Liabilities 134.364141.477143.844101.928106.34492.922117.753119.194141.16103.463130.13195.823127.36994.72991.85375.70792.6462.40452.38539.85838.70535.47232.5770
Non-Current Liabilities:
Long Term Debt 1,717.5991,715.9321,735.711,735.031,733.6291,728.871,723.5641,711.6931,707.4551,723.5441,726.1711,393.9971,396.4771,375.061494.329480.13475.676472.52799.79175.01774.99754.86154.5070
Deferred Revenue Non-Current 16.96119.89000009.20000000000000000
Deferred Tax Liabilities Non-Current 7.0598.29700000-9.20000000000000000
Other Non-Current Liabilities 0.4850.5959.36111.78513.32617.50126.64328.22628.63126.82922.06927.57813.26511.6129.5213.4699.3992.7973.5271.388479.3910.38479.360
Total Non-Current Liabilities 1,742.1041,744.7141,745.0711,746.8151,746.9551,746.3711,750.2071,739.9191,736.0861,750.3731,748.241,421.5751,409.7421,386.673503.849493.599485.075475.324103.31876.405554.38855.241533.8670
Total Liabilities 1,876.4681,886.1911,888.9151,848.7431,853.2991,839.2931,867.961,859.1131,877.2461,853.8361,878.3711,517.3981,537.1111,481.402595.702569.306577.715537.728155.703116.263593.09390.713566.4440
Equity:
Preferred Stock 0000000000000000002.24300.175479.0440.122143.867
Common Stock 0.1940.1930.1810.180.1680.1670.1570.1560.1540.1540.1540.1530.1530.1520.1250.1250.1250.1240.1240.1179.9490.16.5940
Retained Earnings -2,669.173-2,595.717-2,560.501-2,392.353-2,215.354-2,057.455-1,918.149-1,780.558-1,643.219-1,633.363-1,436.966-1,289.789-1,133.854-1,037.506-888.755-768.774-652.915-531.881-440.031-366.573-326.068-234.733-170.580
Accumulated Other Comprehensive Income/Loss -0.0040.0020.0310.0340.063-0.012-0.328-0.348-0.427-0.383-0.1320.0190.036-0.0570.1920.4610.8580.7260.2540.1520-479.044-0.231-61.427
Other Total Stockholders Equity 1,576.0581,545.9941,206.0321,184.596853.1831.635663.703642.333617.96592.596566.53546.22669.371642.117946.344931.944917.691911.746845.864826.062-0.1757.730.1093.331
Total Shareholders Equity -1,092.925-1,049.528-1,354.257-1,207.543-1,362.023-1,225.665-1,254.617-1,138.417-1,025.532-1,040.996-870.414-743.397-464.294-395.29457.906163.756265.759380.715408.454459.758-316.119252.141-163.98685.771
Total Equity -1,082.093-1,036.858-1,342.535-1,193.735-1,349.638-1,213.613-1,244.924-1,130.373-1,015.013-1,040.687-865.579-735.874-455.625-388.094107.886218.387327.512452.071475.976524.267-267.553310.661-101.50385.771
Total Liabilities & Shareholders Equity 794.375849.333546.38655.008503.661625.68623.036728.74862.233813.1491,012.792781.5241,081.4861,093.308703.588787.693905.227989.799631.679640.53325.54401.374464.94185.771